File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Erratum: Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis (Theranostics (2020) 10: 16 (7319-7334) DOI: 10.7150/thno.44054)

TitleErratum: Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis (Theranostics (2020) 10: 16 (7319-7334) DOI: 10.7150/thno.44054)
Authors
Issue Date2022
Citation
Theranostics, 2022, v. 27, n. 1, p. 421 How to Cite?
AbstractThe authors apologize for the original version of our paper unfortunately contained an incorrect representative image of immunohistochemical (IHC) staining for IRF1. Noting that 200x IHC images in the first submitted version were correct. For presenting high resolution images according to one of the reviewer's suggestion, we assembled 400x IHC images in our revised manuscript. IHC staining for IRF1 in the group of Gly + SFN 25 mg/kg was misused as Gly + SFN 50 mg/kg. We apologize that at the time of figure assembly, we choose representative images by mistake. We apologize for our careless at the time of figure assembly. We confirm that it would not affect any results and conclusions of the paper. The correct representative images for Figure 2A are shown below. The authors apologize for any inconvenience that this error may have caused.
Persistent Identifierhttp://hdl.handle.net/10722/369557

 

DC FieldValueLanguage
dc.contributor.authorLiu, Haoran-
dc.contributor.authorYang, Xiaoqi-
dc.contributor.authorTang, Kun-
dc.contributor.authorYe, Tao-
dc.contributor.authorDuan, Chen-
dc.contributor.authorLv, Peng-
dc.contributor.authorYan, Libin-
dc.contributor.authorWu, Xiaoliang-
dc.contributor.authorChen, Zhiqiang-
dc.contributor.authorLiu, Jianhe-
dc.contributor.authorDeng, Yaoliang-
dc.contributor.authorZeng, Guohua-
dc.contributor.authorXing, Jinchun-
dc.contributor.authorYe, Zhangqun-
dc.contributor.authorXu, Hua-
dc.date.accessioned2026-01-27T09:16:26Z-
dc.date.available2026-01-27T09:16:26Z-
dc.date.issued2022-
dc.identifier.citationTheranostics, 2022, v. 27, n. 1, p. 421-
dc.identifier.urihttp://hdl.handle.net/10722/369557-
dc.description.abstractThe authors apologize for the original version of our paper unfortunately contained an incorrect representative image of immunohistochemical (IHC) staining for IRF1. Noting that 200x IHC images in the first submitted version were correct. For presenting high resolution images according to one of the reviewer's suggestion, we assembled 400x IHC images in our revised manuscript. IHC staining for IRF1 in the group of Gly + SFN 25 mg/kg was misused as Gly + SFN 50 mg/kg. We apologize that at the time of figure assembly, we choose representative images by mistake. We apologize for our careless at the time of figure assembly. We confirm that it would not affect any results and conclusions of the paper. The correct representative images for Figure 2A are shown below. The authors apologize for any inconvenience that this error may have caused.-
dc.languageeng-
dc.relation.ispartofTheranostics-
dc.titleErratum: Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis (Theranostics (2020) 10: 16 (7319-7334) DOI: 10.7150/thno.44054)-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.7150/THNO.68830-
dc.identifier.pmid34987656-
dc.identifier.scopuseid_2-s2.0-85120381275-
dc.identifier.volume27-
dc.identifier.issue1-
dc.identifier.spage421-
dc.identifier.epage-
dc.identifier.eissn1838-7640-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats